pharmacodynamics

LAUSANNE, Switzerland, July 13, 2026 Vandria announced new Phase 1 clinical data demonstrating that its investigational small molecule VNA-318...

Mountain View, California, USA – April 23, 2026 RenovoRx announced that a pharmacokinetic (PK) and pharmacodynamic (PD) data abstract...

ATLANTA, United States, April 7, 2026 Alzamend Neuro, Inc. announced encouraging pharmacodynamic data from its Phase II clinical trial...